Anika Therapeutics (ANIK) Treasury Shares (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 20.01% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 20.01% increase from a year earlier, with the FY2025 full-year figure at $953713.0, up 14.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.2 million, up from $953713.0 in the prior quarter.
• Over the last five years, Treasury Shares for ANIK reached as high as $1.2 million in Q1 2026 and fell as low as $117897.0 in Q4 2022.
• Historically, Treasury Shares has averaged $812817.8 across 5 years, with a median of $843757.5 in 2023.
• Across the five-year window, Treasury Shares plunged 71.43% in 2022 and surged 554.26% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $117897.0 in 2022, then jumped by 554.26% to $771358.0 in 2023, then rose by 8.45% to $836562.0 in 2024, then rose by 14.0% to $953713.0 in 2025, then climbed by 22.16% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $1.2 million in Q1 2026, $953713.0 in Q4 2025, and $957338.0 in Q2 2025.